Women's Health Issues
Volume 16, Issue 2 , Pages 44-55 , March 2006

Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities

  • Rosaly Correa-de-Araujo, MD, MSc, PhD

      Affiliations

    • Agency for Healthcare Research and Quality, Rockville, Maryland
    • Corresponding Author InformationCorrespondence to: Rosaly Correa-de-Araujo, MD, MSc, PhD, Director, Women’s Health and Gender-Based Research, Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850; Phone: 301-427-1550; Fax: 301-427-1562.
    • ,
  • Beth Stevens, MS

      Affiliations

    • Colorado Foundation for Medical Care, Englewood, Colorado
    • ,
  • Ernest Moy, MD

      Affiliations

    • Agency for Healthcare Research and Quality, Rockville, Maryland
    • ,
  • David Nilasena, MD

      Affiliations

    • Centers for Medicare & Medicaid Services
    • ,
  • Francis Chesley, MD

      Affiliations

    • Agency for Healthcare Research and Quality, Rockville, Maryland
    • ,
  • Kelly McDermott, MA

      Affiliations

    • Medstat Group, Inc.

Received 4 October 2004 ,Revised 24 February 2005 ,Accepted 18 April 2005.

References 

  1. Abbott RD , Donahue RP , Kannel WB , Wilson PW . The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study . JAMA (The Journal of the American Medical Association) . 1988;260(23):3456–3460
  2. ACE Inhibitor Myocardial Infarction Collaborative Group . Indications for ACE inhibitors in the early treatment of acute myocardial infarction (Systematic overview of individual data from 100,000 patients in randomized trials) . Circulation . 1998;97(22):2202–2212
  3. Agency for Healthcare Research and Quality . National healthcare disparities report . Rockville, MD: US Department of Health and Human Services; 2003;
  4. Agency for Healthcare Research and Quality . National healthcare quality report . Rockville, MD: US Department of Health and Human Services; 2003;
  5. Agency for Healthcare Research and Quality . National healthcare disparities report . Rockville, MD: US Department of Health and Human Services; 2004;
  6. Agency for Healthcare Research and Quality . National healthcare quality report . Rockville, MD: US Department of Health and Human Services; 2004;
  7. Agency for Healthcare Research and Quality . National healthcare disparities report . Rockville, MD: US Department of Health and Human Services; 2005;
  8. Agency for Healthcare Research and Quality . National healthcare quality report . Rockville, MD: US Department of Health and Human Services; 2005;
  9. American Heart Association (AHA) . Heart disease and stroke statistics–2005 update . Dallas, Texas: AHA; 2005;
  10. Antiplatelet Trialists’ Collaboration . Collaborative overview of randomized trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients . British Medical Journal (Clinical Research Edition) . 1994;308(6921):81–106
  11. Bello N , Mosca L . Epidemiology of coronary heart disease in women . Progress in Cardiovascular Diseases . 2004;46(4):287–295
  12. Beta-Blocker Pooling Project (BBPP) The beta-blocker pooling project research group . Subgroup findings from randomized trials in post infarction patients . European Heart Journal . 1988;9(1):8–16
  13. Califf RM , DeLong ER , Ostbye T , Muhlbaier LH , Chen A , LaPointe NA , et al.   Underuse of aspirin in a referral population with documented coronary artery disease . The American Journal of Cardiology . 2002;89(6):653–661
  14. Canto JG , Shlipak MG , Rogers WJ , Malmgren JA , Frederick PD , Lambrew CT , et al.   Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain . JAMA (The Journal of the American Medical Association) . 2000;283(24):3223–3229
  15. Claesson M , Burell G , Birgander LS , Lindahl B , Asplund K . Psychosocial distress and impaired quality of life—Targets neglected in the secondary prevention in women with ischaemic heart disease . European Journal of Cardiovascular Prevention and Rehabilitation . 2003;10(4):258–266
  16. Colwell JA  American Diabetes Association . Aspirin therapy in diabetes . Diabetes Care . 2004;27(Suppl. 1):S72–S73
  17. Cushman WC , Ford CE , Cutler JA , Margolis KL , Davis BR , Grimm RH , et al.   Success and predictors of blood pressure control in diverse North American settings (The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)) . Journal of Clinical Hypertension . 2002;4(6):393–404
  18. Dagenais GR , Yusuf S , Bourassa MG , Yi Q , Bosch J , Lonn EM , et al.   Effects of ramipril on coronary events in high-risk persons (Results of the heart outcomes prevention evaluation study) . Circulation . 2001;104(5):522–526
  19. de Gevigney G , Mosnier S , Ecochard R , Rabilloud M , Cao D , Excoffier S , et al.   Are women with acute myocardial infarction managed as well as men? Does it have consequences on in-hospital mortality? Analysis of an unselected cohort of 801 women and 1,718 men . Acta Cardiologica . 2001;56(3):169–179
  20. Fiore MC , Bailey WC , Cohen SJ , Dorfman SF , Goldstein MG , Gritz ER . Treating tobacco use and dependence (Clinical practice guidelines) . Rockville, MD: US Department of Health and Human Services; 2000; Public Health Service
  21. Flather MD , Yusuf S , Kober L , Pfeffer M , Hall A , Murray G , et al.  ACE-inhibitor myocardial infarction collaborative group   Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction (A systematic overview of data from individual patients) . Lancet . 2000;355(9215):1575–1581
  22. Food and Drug Administration . FDA approves Bidil heart failure drug for black patients . FDA News . 2005; Available: http://www.fda.gov. Accessed July 9, 2005
  23. Gan SC , Beaver SK , Houck PM , MacLehose RF , Lawson HW , Chan L . Treatment of acute myocardial infarction and 30-day mortality among women and men . The New England Journal of Medicine . 2000;343(1):8–15
  24. Garg R , Yusuf S  Collaborative group on ACE inhibitor trials . Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure . JAMA (The Journal of the American Medical Association) . 1995;273(18):1450–1456
  25. Grady D , Chaput L , Kristof M . Diagnosis and treatment of coronary heart disease in women: Systematic review of evidence on selected topics. Evidence Report/Technology assessment No. 7 . Prepared by the University of California, San Francisco—Stanford Evidence-based Practice Center under contract # 290-97-0013 . Rockville, MD: Agency for Healthcare Research and Quality; 2003;
  26. Grundy SM , Pasternak R , Greenland P , Smith S , Fuster V . Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations (A statement for healthcare professionals from the American Heart Association and the American college of cardiology) . Circulation . 1999;100(13):1481–1492
  27. Henderson SO , Magana RN , Korn CS , Genna T , Bretsky PM . Delayed presentation for care during acute myocardial infarction in a Hispanic population of Los Angeles county . Ethnicity & Disease . 2002;12(1):38–44
  28. Horowitz CR , Rein SB , Leventhal H . A story of maladies, misconceptions and mishaps (Effective management of heart failure) . Social Science & Medicine . 2004;58(3):631–643
  29. ICD-9-CM . International Classification of Diseases . Los Angeles: PMIC; 2002; 9th Revision; Clinical Modification Hospital Edition
  30. Jonas M , Reicher-Reiss H , Boyko V , Shotan A , Mandelzweig L , Goldbourt U , et al.  Bezafibrate Infarction Prevention (BIP) study group   Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease . The American Journal of Cardiology . 1996;77(15):1273–1277
  31. Kendall MJ , Lynch KP , Hjalmarson A , Kjekshus J . Beta-blockers and sudden cardiac death . Annals of Internal Medicine . 1995;123(5):358–367
  32. Krein SL , Vijan S , Pogach LM , Hogan MM , Kerr EA . Aspirin use and counseling about aspirin among patients with diabetes . Diabetes Care . 2002;25(6):965–970
  33. Krumholz HM , Chen J , Chen YT , Wang Y , Radford MJ . Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction (Results from the cooperative cardiovascular project) . Journal of the American College of Cardiology . 2001;38(2):453–459
  34. Lonn E , Roccaforte R , Yi Q , Dagenais G , Sleight P , Bosch J , et al.   Effect of long-term therapy with ramipril in high-risk women . Journal of the American College of Cardiology . 2002;40(4):693–702
  35. Masoudi FA , Rathore SS , Wang Y , Havranek EP , Curtis JP , Foody JM , et al.   National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction . Circulation . 2004;110(6):724–731
  36. Mosca L , Appel LJ , Benjamin EJ , Berra K , Chandra-Strobos N , Fabunmi RP , et al.   Evidence-based guidelines for cardiovascular disease prevention in women . Circulation . 2004;109(5):672–693
  37. Mosca L , Ferris A , Fabunmi R , Robertson RM  American Heart Association . Tracking women’s awareness of heart disease (An American Heart Association national study) . Circulation . 2004;109(5):573–579
  38. Mosca L , Manson JE , Sutherland SE , Langer RD , Manolio T , Barrett-Connor E . Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association. writing group . Circulation . 1997;96(7):2468–2482
  39. Multicenter Postinfarction Research Group . Risk stratification and survival after myocardial infarction . New England Journal of Medicine . 1983;309:331–336
  40. Njolstad I , Arnesen E , Lund-Larsen PG . Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study . Circulation . 1996;93(3):450–456
  41. O’Connor PJ , Pronk NP , Tan AW , Rush WA , Gray RJ . Does professional advice influence aspirin use to prevent heart disease in an HMO population? . Effective Clinical Practice . 1998;1(1):26–32
  42. Olsson G , Wikstrand J , Warnold I , Manger Cats V , McBoyle D , Herlitz J , et al.   Metoprolol-induced reduction in postinfarction mortality (Pooled results from five double-blind randomized trials) . European Heart Journal . 1992;13(1):28–32
  43. Patel AR , Konstam MA . Recent advances in the treatment of heart failure . Circulation . 2002;66(2):117–121
  44. Pijna IL , Buchter C . Heart failure in women . Cardiology in Review . 2003;11(6):337–344
  45. Prichard BNC , Cruickshank JM , Graham B . Beta-blockers in the third millenium—When are they really indicated? . Journal of Clinical and Basic Cardiology . 2001;4:3–9
  46. Rea TD , Heckbert SR , Kaplan RC , Smith NL , Lemaitre RN , Psaty BM . Smoking status and risk for recurrent coronary events after myocardial infarction . Annals of Internal Medicine . 2002;137(6):494–500
  47. Roig E , Magrina J , Garcia A , Armengol X , Muxi A , Melis G , et al.   Prognostic value of exercise radionuclide angiography in low risk acute myocardial infarction survivors . European Heart Journal . 1993;14(2):213–218
  48. Rolka DB , Fagot-Campagna A , Narayan KM . Aspirin use among adults with diabetes (Estimates from the third national health and nutrition examination survey) . Diabetes Care . 2001;24(2):197–201
  49. Saltzberg S , Stroh JA , Frishman WH . Isolated systolic hypertension in the elderly (Pathophysiology and treatment) . The Medical Clinics of North America . 1988;72(2):523–547
  50. Schaefer BM , Caracciolo V , Frishman WH , Charney P . Gender, ethnicity, and genes in cardiovascular disease. Part 2: Implications for pharmacotherapy . Heart Disease . 2003;5(3):202–214
  51. Shlipak MG . Pharmacotherapy for heart failure in patients with renal insufficiency . Annals of Internal Medicine . 2003;138(11):917–924
  52. Shorr RI , Ray WA , Daugherty JR , Griffin MR . Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas . JAMA (The Journal of the American Medical Association) . 1997;278(1):40–43
  53. Soumerai SB , McLaughlin TJ , Spiegelman D , Hertzmark E , Thibault G , Goldman L . Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction . JAMA (The Journal of the American Medical Association) . 1997;277(2):115–121
  54. Stewart DE , Abbey SE , Shnek ZM , Irvine J , Grace SL . Gender differences in health information needs and decisional preferences in patients recovering from an acute ischemic coronary event . Psychosomatic Medicine . 2004;66(1):42–48
  55. Suarez L , Barrett-Connort E . Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease . American Journal of Epidemiology . 1984;120(5):670–675
  56. Tenenbaum A , Fisman EZ , Schwammenthal E , Adler Y , Benderly M , Motro M , et al.   Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitus . Cardiovascular Diabetology . 2003;2(1):14
  57. Vaccarino V , Krumholz HM , Yarzebski J , Gore JM , Goldberg RJ . Sex differences in 2-year mortality after hospital discharge for myocardial infarction . Annals of Internal Medicine . 2001;134(3):173–181
  58. Whitlock EP , Williams SB . The primary prevention of heart disease in women through health behavior change promotion in primary care . Women’s Health Issues . 2003;13(4):122–141
  59. Yudkin JS . Which diabetic patients should be taking aspirin? . British Medical Journal . 1995;311(7006):641–642 (Clinical Research Edition)
  60. Yusuf S , Sleight P , Pogue J , Bosch J , Davies R , Dagenais G  The heart outcomes prevention evaluation study investigators . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients . The New England Journal of Medicine . 2000;342(3):145–153

 The views expressed in this article are those of the authors and do not necessarily represent the views of the Agency for Healthcare Research and Quality or the Federal government.

PII: S1049-3867(05)00061-7

doi: 10.1016/j.whi.2005.04.003

Women's Health Issues
Volume 16, Issue 2 , Pages 44-55 , March 2006

Article Tools